MSB 0.51% 97.0¢ mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-865

  1. 2,827 Posts.
    lightbulb Created with Sketch. 1942
    We refile
    Fda takes up to 30 days to respond if it is accepted.
    If accepted they issue a PDUFA date depending on whether they deem it to be a class 1 or class 2 resubmission.
    Class 1 is max two months from date we refiled- Class 2 is max 6 months from date we refiled.

    First submission was a PDUFA date of 6 months.

    Second was a PDUFA date of 5 months.

    FDA can shorten the time frames in both classes but rarely exceed the timeline.

    Class 2 will happen if the new data file submitted is enormous.

    We will get a date less than 5 months. Everything else is speculation.

    I figure the board will want a result prior to the annual meeting.

    Reg
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.0¢
Change
-0.005(0.51%)
Mkt cap ! $1.107B
Open High Low Value Volume
98.5¢ 98.5¢ 96.0¢ $2.168M 2.226M

Buyers (Bids)

No. Vol. Price($)
1 16000 96.5¢
 

Sellers (Offers)

Price($) Vol. No.
97.0¢ 86854 7
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.